Diagnostic approach to phlogoses: the validity of procalcitonin


Submitted: 17 November 2014
Accepted: 17 November 2014
Published: 31 December 2013
Abstract Views: 889
PDF: 4811
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • E. Dimitri Clinica Pediatrica dell’Università Politecnica delle Marche–Azienda Ospedaliera, “G.Salesi” degli Ospedali Riuniti di Ancona, Ancona, Italy.
  • V. Amialyanchyk Dipartimento di Radiologia Clinica dell’Università Politecnica delle Marche degli Ospedali Riuniti di Ancona, Ancona, Italy.
  • F. Bordicchia Laboratorio Analisi, Azienda Ospedaliera “G.Salesi” degli Ospedali Riuniti di Ancona, Ancona, Italy.
  • G. D’Angelo Clinica Pediatrica dell’Università Politecnica delle Marche–Azienda Ospedaliera, “G.Salesi” degli Ospedali Riuniti di Ancona, Ancona, Italy.
Aim. The aim of our study is to compare the potential usefulness of procalcitonin with the CRP as a diagnostic marker of pediatric diseases and to define the diagnostic accuracy and relation with the inflammation etiology and severity of procalcitonin. Methods. The analysis focused on a sample of 141 children, hospitalized for fever with bacterial, viral or inflammatory etiology, studied at the time of admission in the Hospital, and after defervescence. The sensitivity, the specificity, the positive and negative predictive value have been calculated for the both tests, explained above. Results. The diagnostic accuracy of procalcitonin is the same as the one of PCR in all cases. The result of the test has been positive in 85,7% of the serious infections and has been useful to identifiy the etiology of infections in almost 2/3 of patients. Conclusion. Procalcitonin seems to be a promising marker of infections because of its following features: a larger contribution in the monitoring phase (fast positivization and normalization); the diagnostic accuracy and a good correlation with the etiology and the severity of infections. Nonetheless, the routine use of procalcitonin is not recommended in the light of

Dimitri, E., Amialyanchyk, V., Bordicchia, F., & D’Angelo, G. (2013). Diagnostic approach to phlogoses: the validity of procalcitonin. La Pediatria Medica E Chirurgica, 35(6). https://doi.org/10.4081/pmc.2013.24

Downloads

Download data is not yet available.

Citations